Shareholders' equity · 2011–2025
TG Therapeutics shareholders' equity
$648M+191.4% · FY2025
TG Therapeutics (TGTX) reported $648M in shareholders' equity for fiscal 2025, +191.4% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $648M | +191.4% | Open → |
| FY20242024-12-31 | $222M | +38.5% | Open → |
| FY20232023-12-31 | $161M | +174.0% | Open → |
| FY20222022-12-31 | $58.6M | −75.3% | Open → |
| FY20212021-12-31 | $237M | −54.3% | Open → |
| FY20202020-12-31 | $519M | +1,244.9% | Open → |
| FY20192019-12-31 | $38.6M | +60.7% | Open → |
| FY20182018-12-31 | $24.0M | −64.1% | Open → |
| FY20172017-12-31 | $67.0M | +86.8% | Open → |
| FY20162016-12-31 | $35.9M | −64.7% | Open → |
| FY20152015-12-31 | $102M | +26.8% | Open → |
| FY20142014-12-31 | $80.1M | +100.0% | Open → |
| FY20132013-12-31 | $40.1M | +157.6% | Open → |
| FY20122012-12-31 | $15.6M | +61.6% | Open → |
| FY20112011-12-31 | $9.6M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +35.1%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=TG Therapeutics shareholders' equity |url=https://companiesranked.com/en/company/tg-therapeutics/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). TG Therapeutics shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/tg-therapeutics/shareholders-equityBibTeX
@misc{companiesranked-en-company-tg-therapeutics-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{TG Therapeutics shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/tg-therapeutics/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001437749-26-025955 · August 5, 2026
{{cite web |title=TG Therapeutics shareholders' equity — 10-Q (0001437749-26-025955) |url=https://www.sec.gov/Archives/edgar/data/1001316/000143774926025955/tgtx20260630_10q.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.